VF
HUMA icon

Virtu Financial’s Humacyte HUMA Stock Holding History

Virtu Financial’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Buy
462,298
+403,528
+687% +$374K 0.01% 654
2026
Q1 		$36K Sell
58,770
-203,955
-78% -$212K ﹤0.01% 1330
2025
Q4 		$252K Buy
+262,725
New +$372K 0.01% 931
2025
Q3 		– Sell
-11,058
Closed -$23K – 1732
2025
Q2 		$23K Buy
+11,058
New +$21.2K ﹤0.01% 1242
2024
Q4 		– Sell
-40,102
Closed -$218K – 1758
2024
Q3 		$218K Sell
40,102
-63,061
-61% -$416K 0.01% 765
2024
Q2 		$495K Buy
103,163
+39,760
+63% +$207K 0.03% 449
2024
Q1 		$197K Buy
+63,403
New +$213K 0.02% 796
2022
Q1 		– Sell
-19,851
Closed -$144K – 1720
2021
Q4 		$144K Buy
+19,851
New +$196K 0.01% 966

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Virtu Financial's HUMA Position: Q2 2026 in Review

Virtu Financial increased its Humacyte (HUMA) stake by 687% in Q2 2026, buying an estimated $374K and bringing the position to 462,298 shares worth $361K. The position accounts for 0.01% of the portfolio, ranked #654.

Virtu Financial first reported a position in HUMA in Q4 2021 and has held it in 8 quarters since. The position peaked at $495K in Q2 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Virtu Financial held 462,298 shares of Humacyte worth $361K as of Q2 2026.
  • Virtu Financial bought 403,528 Humacyte shares in Q2 2026, an estimated $374K.
  • Humacyte made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #654 holding.
  • Virtu Financial first reported a position in Humacyte in Q4 2021 and has held it in 8 quarters since.
  • Virtu Financial's Humacyte position peaked at $495K in Q2 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.